CD34 and systemic sclerosis: Whereas some studies reported a significant depletion in the count of CD34+/CD133+/VEGFR2+ cells in SSc patients using flow-cytometry (40, 45–47), other studies found increased circulating EPC counts, mainly in the early and active stages of the disease (41–43).